Abstract
Changing Trends in the Risk Factors of Secondary Primary Malignancies after Autologous Stem Cell Transplantation for Multiple Myeloma before and after the Introduction of Proteasome Inhibitors/Immunomodulatory Agents
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have